Tag Archives: lung

FDA Approves Libtayo (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-Small Cell Lung Cancer with PD-L1 Expression of ≥50%

TARRYTOWN, N.Y. and PARIS, Feb. 22, 2021 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food and Drug Administration (FDA) has approved the PD-1 inhibitor Libtayo (cemiplimab-rwlc) for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression (tumor proportion score ≥50%), as determined by an… Read More »

FDA Approves Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

FDA Approves Gavreto (pralsetinib) for the Treatment of Adults With Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer Print this page South San Francisco, CA — September 4, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto (pralsetinib)… Read More »

Imfinzi (durvalumab) Approved in the US for Extensive-Stage Small Cell Lung Cancer

Print this page 30 March 2020 — AstraZeneca’s Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide). The approval by the Food and Drug Administration was based on positive results from… Read More »

Scientists publish scans showing lung damage caused by vaping in teenagers with EVALI

Scientists publish scans showing lung damage caused by vaping in teenagers as young as 13 who became ill with EVALI Fourteen teenagers with respiratory symptoms were studied by docs in the US They all had symptoms of EVALI, a new disease linked to rise of e-cigarette use Researchers found that 36% of their patients had visible damage to… Read More »